Cancer drugs: Better, cheaper
Monday, June 4, 2012 - 20:30
in Health & Medicine
Cancer drug development is known to be too slow, costly and fraught with failure. Now the US Food and Drug Administration is issuing recommendations for breast cancer trials that would substantially accelerate patient access to new medications while lowering the time and cost of drug development.